Op De Beéck, Katrijn, Vermeersch, Pieter, Verschueren, Patrick et al. · Autoimmunity reviews · 2012 · DOI
This study compared two different blood tests for detecting autoantibodies (proteins the immune system makes that attack the body's own cells) in patients with various autoimmune diseases and in people with ME/CFS. The researchers found that one newer automated test missed some antibodies that an older, more traditional test detected, and that having multiple antibodies together was much more common in autoimmune disease patients than in ME/CFS patients.
For ME/CFS patients, this study is important because it demonstrates that autoantibody profiles in ME/CFS are fundamentally different from classical autoimmune diseases—very few ME/CFS patients have multiple autoantibodies, which helps clarify that ME/CFS is not primarily an autoimmune connective tissue disorder. Understanding these immunological distinctions helps prevent ME/CFS from being misdiagnosed as lupus or other systemic autoimmune conditions, which could lead to inappropriate treatment.
This study does not prove that ME/CFS has no autoimmune component, only that the pattern of nuclear autoantibodies differs from systemic rheumatic diseases. It does not establish whether any role autoantibodies might play in ME/CFS pathophysiology or whether other immune markers beyond nuclear antibodies are abnormal in ME/CFS. The cross-sectional design cannot determine whether autoantibody profiles change over the course of ME/CFS illness.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →